What is Panayiotopoulos syndrome and how does it present?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 18, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Panayiotopoulos Syndrome

Panayiotopoulos syndrome is a common, benign childhood epilepsy characterized by prolonged seizures with predominantly autonomic symptoms (especially vomiting), occurring in early to mid-childhood with an excellent prognosis despite frequently being misdiagnosed as acute non-epileptic conditions. 1

Definition and Epidemiology

  • Panayiotopoulos syndrome is formally recognized by the International League Against Epilepsy as a benign age-related focal seizure disorder occurring primarily between ages 3-6 years, characterized by seizures with predominantly autonomic symptoms and an EEG showing shifting and/or multiple foci, often with occipital predominance. 1

  • The syndrome affects approximately 13% of children aged 3-6 years who have had one or more afebrile seizures and 6% of children aged 1-15 years with afebrile seizures. 1

  • Two-thirds of seizures occur during sleep. 1

Clinical Presentation

Cardinal Autonomic Features

  • Emesis (vomiting) is the predominant and most characteristic symptom, occurring in 78% of patients presenting to emergency settings. 2

  • Other autonomic manifestations include:

    • Pallor (or less commonly flushing or cyanosis) 1
    • Mydriasis (or less commonly miosis) 1
    • Cardiorespiratory and thermoregulatory alterations 1
    • Urinary and/or fecal incontinence 1
    • Hypersalivation and altered intestinal motility 1

Seizure Characteristics

  • Half of all seizures last longer than 30 minutes, constituting autonomic status epilepticus, which is the most common form of nonconvulsive status epilepticus in otherwise normal children. 1

  • In approximately one-fifth of seizures, the child becomes unresponsive and flaccid (ictal syncope) before or without convulsions. 1

  • Only half of seizures end with brief hemiconvulsions or generalized convulsions; convulsive status epilepticus is extremely rare. 1

  • Autonomic symptoms may be the only features of the seizures without any motor manifestations. 1

Unusual Presentations

  • Ictal syncope or syncope-like epileptic seizures occur in 29.2% of cases. 3

  • Hyperthermia without acute febrile illness with autonomic symptoms occurs in 14.6% of patients. 3

  • Ictal headache as initial manifestation followed by nausea and vomiting occurs in 9.7% of cases. 3

  • Rare presentations include hiccups, laughter, vertigo, coughing, and oral automatisms, all accompanied by autonomic symptoms. 3

  • Cardiorespiratory arrest is exceptional but has been reported in rare cases. 1, 3

Electroencephalographic Features

  • EEG shows multiple spikes in various brain locations with shifting and/or multiple foci, often with occipital predominance. 1

  • High-amplitude sharp-slow wave complexes at various locations can be present. 4

  • EEG is the only investigation that typically shows abnormal results. 1

Differential Diagnosis and Common Misdiagnoses

Frequently Confused Conditions

  • The clinical features are frequently mistaken for acute encephalitis, syncope, migraine, cyclic vomiting syndrome, motion sickness, sleep disorders, or gastroenteritis, leading to avoidable misdiagnosis, high morbidity, and costly mismanagement. 1, 5

Key Differentiating Features from Acute Encephalopathy

  • Convulsive seizures in Panayiotopoulos syndrome are typically shorter than 15 minutes (only 17% have convulsions ≥15 minutes), whereas 90% of acute encephalopathy patients have convulsive seizures ≥15 minutes. 2

  • Seizures in Panayiotopoulos syndrome are treatable with small doses of midazolam (0.1 mg/kg), whereas acute encephalopathy requires 0.3 mg/kg or more. 2

  • Fever is present in all acute encephalopathy patients (100%) but only 11% of Panayiotopoulos syndrome patients. 2

  • Non-convulsive status epilepticus occurs in 22% of Panayiotopoulos syndrome patients but not in acute encephalopathy. 2

Prognosis and Long-Term Outcomes

Seizure Prognosis

  • Panayiotopoulos syndrome is remarkably benign in terms of seizure frequency and evolution. 1

  • Autonomic status epilepticus imparts no residual neurologic deficit. 1

  • The risk of epilepsy in adult life appears to be no higher than in the general population. 1

  • Seizures are self-limiting and do not usually continue into adulthood. 6

Neurocognitive and Behavioral Considerations

  • Children with Panayiotopoulos syndrome demonstrate diffuse cognitive dysfunction with mean full-scale IQ (93.5) and performance IQ (93.2) significantly lower than normative means, though still within normal range. 7

  • Simple auditory/visual reaction times, visual attention, visual-motor integration, and verbal memory are significantly impaired compared to normative values. 7

  • Patients average 8 months behind in arithmetic speed and 11 months behind in reading speed for their time in school. 7

  • A high incidence of internalizing behavioral problems (anxiety, depression, withdrawal) is reported. 7

  • Mild-to-severe academic underachievement is present in more than half of affected children. 7

Rare Long-Term Evolution

  • Four documented cases exist of Panayiotopoulos syndrome evolving to juvenile myoclonic epilepsy in adolescence, with intervals of 1-10 years between last Panayiotopoulos syndrome seizure and first juvenile myoclonic epilepsy seizure. 6

Management Principles

  • Education about Panayiotopoulos syndrome is the cornerstone of management. 1

  • Prophylactic treatment with antiepileptic medication may not be needed for most patients given the benign nature and self-limited course. 1

  • Autonomic status epilepticus in the acute stage needs thorough evaluation; aggressive treatment may cause iatrogenic complications including cardiorespiratory arrest. 1

  • Availability of EEG recording in pediatric emergency departments is useful for prompt and cost-effective diagnosis. 5

Critical Clinical Pitfalls

  • Failing to recognize the predominantly autonomic nature of seizures leads to misdiagnosis as gastroenteritis or other non-epileptic conditions. 1, 5

  • Aggressive treatment of prolonged autonomic seizures can cause iatrogenic harm, including cardiorespiratory complications. 1

  • Assuming good prognosis means no follow-up is needed may miss neurocognitive deficits and behavioral problems that require intervention. 7

  • Not considering Panayiotopoulos syndrome in children with recurrent vomiting episodes and altered consciousness, especially during sleep. 1, 2

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.